A stock trading plan for Healthways co-founder and director Tom Cigarran last Friday exercised more than 80,000 stock options that would have expired later this month and then sold the resulting shares. Cigarran's gain on the transactions amounted to almost $300,000. Good thing shares of Healthways (Ticker: HWAY) are up more than 50 percent in the past three months. Without that run, the options would still be under water.
Turns out there are quite a few people who would like to see the end of Tom Cigarran's two-decade involvement with surgery center operator AmSurg.
At AmSurg's annual meeting of shareholders last week, investors overwhelmingly voted in favor of various par-for-the-course proposals as well as the re-election to three-year terms of directors Cynthia Miller and John Popp. Not so with Cigarran, chairman of AmSurg from 1992 to 2009 and its CEO for four years during the '90s. He received just 58.5 percent of the possible votes.
POSTDATA: WARRANTY DEEDS